RTM Vital SIgns

RTM Vital Signs LLC (RTM) is a biotechnology and healthcare startup founded in 2014 in the United States. The company focuses on developing and commercializing real-time implantable cardiac and acoustic ventilation devices and monitoring systems. Their slogan, "Patented Solutions for Continuous, Real-time, and Accurate Vital Sign Monitoring of Ambulatory Patients," encapsulates their innovative, patented technology designed to continuously monitor arterial blood pressure waveform and other vital sign data of ambulatory patients with cardiovascular disease and those at risk for adverse events. With a recent $280.00K Seed Round investment from CAV Angel Network in November 2020, RTM is making strides in advancing its mission. The technology provided by RTM enables physicians, nurses, and emergency personnel to track recorded vital sign data, observe trends, determine the cause of new patient symptoms, and evaluate the effectiveness of medical therapy. RTM Vital Signs operates at the intersection of biotechnology, healthcare, and information technology, positioning itself as a significant player in monitoring and improving the well-being of ambulatory patients. With its innovative solutions, the company addresses critical needs in healthcare and has the potential to carve out a substantial market share in the coming years.